Effect of Drug Treatment on Quality of Life in Mild to Moderate Heart Failure
- 1 January 1991
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 6 (4), 241-246
- https://doi.org/10.2165/00002018-199106040-00002
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failureThe American Journal of Cardiology, 1989
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Analysis of quality of life data from a randomized, placebo-controlled heart-failure trialJournal of Clinical Epidemiology, 1988
- Lisinopril versus placebo in older congestive heart failure patientsThe American Journal of Medicine, 1988
- How should we measure function in patients with chronic heart and lung disease?Journal of Chronic Diseases, 1985
- Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failureJournal of the American College of Cardiology, 1985
- Pitfalls in the serial assessment of cardiac functional statusJournal of Chronic Diseases, 1982
- Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.Circulation, 1981
- Long-term therapy of heart failure with prazosin: A randomized double blind trialThe American Journal of Cardiology, 1980
- Major Changes Made by Criteria Committee of the New York Heart AssociationCirculation, 1974